About ImmuNovus
ImmuNovus is a private company based in Denton, Nebraska, incorporated in 2022 in Delaware. It has reported $1,000,000 raised in one offering on Form D since July 2026. Its chief executive is Tomas Helikar.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | Jul 29, 2026amended Jul 29, 2026 | $1,000,000of $5.0M target | 2 | $500K | Simple Agreement for Future Equity (SAFE)Rule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on ImmuNovus's Form D filed Jul 29, 2026.
TH